Published in Anticancer Res on August 04, 2003
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer. J Clin Oncol (2010) 3.88
Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer (2004) 2.38
Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. World J Gastroenterol (2009) 1.88
Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial. J Natl Cancer Inst (2013) 1.28
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer (2003) 1.19
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area. Breast Cancer Res (2005) 1.19
Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces. Mol Cancer Res (2008) 1.14
Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest (2007) 1.07
Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer (2003) 1.06
Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J (2009) 1.05
New biological temporary skin cover Xe-Derma(®) in the treatment of superficial scald burns in children. Burns (2010) 0.98
Endovascular treatment of central vein stenoses and/or occlusions in hemodialysis patients. Cardiovasc Intervent Radiol (2002) 0.96
Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol (2013) 0.96
The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Res Treat (2005) 0.88
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat (2010) 0.87
Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat (2006) 0.87
Lung cancer risk among Czech women: a case-control study. Prev Med (2002) 0.87
The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. Cancer Epidemiol Biomarkers Prev (2013) 0.87
Human keratinocyte growth and differentiation on acellular porcine dermal matrix in relation to wound healing potential. ScientificWorldJournal (2012) 0.86
Breast cancer risk assessment in the Czech female population--an adjustment of the original Gail model. Breast Cancer Res Treat (2005) 0.86
Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study. Expert Opin Pharmacother (2003) 0.85
Gemcitabine/carboplatin in advanced non-small cell lung cancer. Lung Cancer (2002) 0.85
Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer. Hepatogastroenterology (2002) 0.83
Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer (2011) 0.83
Neoplastic progression of the human breast cancer cell line G3S1 is associated with elevation of cytoskeletal dynamics and upregulation of MT1-MMP. Int J Oncol (2010) 0.82
Proving tumour cells by acute nutritional/energy deprivation as a survival threat: a task for microscopy. Anticancer Res (2009) 0.82
Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology. Breast Cancer Res Treat (2013) 0.82
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients. Melanoma Res (2005) 0.81
Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme. BMC Public Health (2011) 0.80
Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins. BMC Cancer (2010) 0.80
Ultrasound-guided cryoablation of breast fibroadenoma: a pilot trial. Arch Gynecol Obstet (2014) 0.80
4-years results of weekly trastuzumab and paclitaxel in the treatment of women with HER2/neu overexpressing advanced breast cancer: single institution prospective study. Bull Cancer (2004) 0.80
Adaptation of a CXCR4-using human immunodeficiency type 1 NDK virus in intestinal cells is associated with CD4-independent replication. Virology (2002) 0.79
Arising podosomal structures are associated with neoplastic cell morphological phenotype induced by the microenvironment. Anticancer Res (2006) 0.79
Role of DNA methylation in expression and transmission of porcine endogenous retroviruses. J Virol (2013) 0.78
A simple non-destructive test of cellular activity (NTCA) for in vitro assessment of cancer cell chemosensitivity/resistance. Anticancer Res (2007) 0.78
Computer-aided evaluation of screening mammograms based on local texture models. IEEE Trans Image Process (2009) 0.77
Symptomatic control of hypoglycaemia with prednisone in refractory metastatic pancreatic insulinoma. Support Care Cancer (2005) 0.77
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer. Anticancer Res (2013) 0.77
Mesenchymal stem cells seeded on cross-linked and noncross-linked acellular porcine dermal scaffolds for long-term full-thickness hernia repair in a small animal model. Artif Organs (2013) 0.76
Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. J Clin Invest (2015) 0.76
Origin of cells cultured in vitro from human breast carcinomas traced by cyclin D1 and HER2/neu FISH signal numbers. Anticancer Res (2005) 0.76
Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Neuro Endocrinol Lett (2008) 0.75
[Oxidative stress after anthracycline therapy in patients with solid tumors]. Cas Lek Cesk (2012) 0.75
Breast cancer characteristics-comparison of preoperative and postoperative values. Pathol Res Pract (2013) 0.75
Survival after oxaliplatin therapy of irinotecan-pretreated advanced colorectal cancer patients. Hepatogastroenterology (2005) 0.75
Impact of the nucleosome histone core on the structure and dynamics of DNA containing pyrimidine-pyrimidone (6-4) photoproduct. J Chem Theory Comput (2020) 0.75
[News from the 13th European Cancer Conference (ECCO-13)]. Cas Lek Cesk (2006) 0.75
Assessment of the potential risk of infection associated with Clostridium difficile from porcine xenografts. Xenotransplantation (2009) 0.75
A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer. Clin Cancer Res (2006) 0.75
Highlights from the 7th central European lung cancer conference. Lung Cancer (2002) 0.75